Jane E Cavanaugh
Overview
Explore the profile of Jane E Cavanaugh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
414
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Parker S, Hough A, Wright T, Lax N, Faruk A, Fofie C, et al.
Molecules
. 2025 Feb;
30(3).
PMID: 39942783
Marine cyanobacteria have gained momentum in recent years as a source of novel bioactive small molecules. This paper describes the structure elucidation and pharmacological evaluation of two new (veraguamide O...
2.
Parker S, Hough A, Wright T, Lax N, Faruk A, Fofie C, et al.
bioRxiv
. 2025 Feb;
PMID: 39896503
Marine cyanobacteria have gained momentum in recent years as a source of novel bioactive small molecules. This paper describes the structure elucidation and pharmacological evaluation of two new, veraguamide O...
3.
Hough A, Criswell C, Faruk A, Cavanaugh J, Kolber B, Tidgewell K
Mar Drugs
. 2023 Feb;
21(2).
PMID: 36827151
Marine cyanobacteria are a rich source of bio-active metabolites that have been utilized as leads for drug discovery and pharmacological tools for basic science research. Here, we describe the re-isolation...
4.
Nguyen K, Tran M, Rivera A, Cheng T, Windsor G, Chabot A, et al.
Front Biosci (Landmark Ed)
. 2022 May;
27(5):167.
PMID: 35638434
The mitogen-activated protein kinase (MAPK) pathways are ubiquitous in cellular signaling and are essential for proper biological functions. Disruptions in this signaling axis can lead to diseases such as the...
5.
Matossian M, Hoang V, Burks H, La J, Elliott S, Brock C, et al.
Oncoscience
. 2021 May;
8:64-71.
PMID: 34026925
Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limited targeted therapeutic options. A defining feature of TNBC is the propensity to metastasize and acquire resistance...
6.
Hoang V, Matossian M, La J, Hoang K, Ucar D, Elliott S, et al.
J Cell Biochem
. 2021 Apr;
122(8):835-850.
PMID: 33876843
Triple-negative breast cancer (TNBC) presents a clinical challenge due to the aggressive nature of the disease and a lack of targeted therapies. Constitutive activation of the mitogen-activated protein kinase (MAPK)/extracellular...
7.
Bhatt A, Wright T, Barnes V, Chakrabarty S, Matossian M, Lexner E, et al.
Transl Oncol
. 2021 Mar;
14(6):101046.
PMID: 33761370
The epithelial to mesenchymal transition (EMT) is characterized by a loss of cell polarity, a decrease in the epithelial cell marker E-cadherin, and an increase in mesenchymal markers including the...
8.
Bhatt A, Patel S, Matossian M, Ucar D, Miele L, Burow M, et al.
Biomolecules
. 2021 Feb;
11(2).
PMID: 33572742
Extracellular signal-regulated kinase (ERK5) is an essential regulator of cancer progression, tumor relapse, and poor patient survival. Epithelial to mesenchymal transition (EMT) is a complex oncogenic process, which drives cell...
9.
Hoang V, Matossian M, Ucar D, Elliott S, La J, Wright M, et al.
Front Oncol
. 2020 Aug;
10:1164.
PMID: 32850332
Conventional mitogen-activated protein kinase (MAPK) family members regulate diverse cellular processes involved in tumor initiation and progression, yet the role of ERK5 in cancer biology is not fully understood. Triple-negative...
10.
Wright T, Raybuck C, Bhatt A, Monlish D, Chakrabarty S, Wendekier K, et al.
J Cell Biochem
. 2019 Aug;
121(2):1156-1168.
PMID: 31464004
Triple-negative breast cancers (TNBCs) represent 15% to 20% of all breast cancers and are often associated with poor prognosis. The lack of targeted therapies for TNBCs contributes to higher mortality...